San Mateo, CA – According to filings with the U.S. Securities and Exchange Commission, Sonomotion is raising $14,358,500.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Oren Levy played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Sonomotion

Sonomotion is a medical device startup that is developing non-invasive solutions for the treatment of kidney stones. The companys stone repositioning solution is currently in clinical trials and its second generation stone breaking technology is in development. Each year, more than three million Americans see a physician for kidney stones and over 700,000 procedures are performed to break large kidney stones. SonoMotion is developing non-invasive solutions for kidney stone disease with two breakthrough products. Break Wave will fragment large kidney stones faster, safer and more effectively than existing options. And Stone Clear, which is currently in clinical trials, will help clear the resulting stone fragments within 15 minutes in an office setting and also without general anesthesia or x-ray radiation.

To learn more about Sonomotion, visit http://www.sonomotion.com/

Contact:
Oren Levy, Chief Executive Officer
415-672-2631
oren@sonomotion.com
https://www.linkedin.com/in/oren-levy-9ba20a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved